Zydus Lifesciences Q2 Profit Falls 26.6% as Expenses Outpace Revenue Growth
Consolidated net profit fell to 9.26 billion rupees for the July-September quarter from 12…; shares were about 4% lower.
Indian drugmaker Zydus Lifesciences NSE:ZYDUSLIFE reported a 26.6% fall in second-quarter profit on Wednesday, as rising expenses outweighed stronger demand, pushing its shares about 4% lower.Consolidated net profit fell to 9.26 billion rupees ($97.77 million) for the July-September quarter from 12…